Establishment of a highly metastatic human ovarian cancer cell line (HO-8910PM) and its characterization.
about
P1343
SPARC is a key regulator of proliferation, apoptosis and invasion in human ovarian cancer.Characterization of three new serous epithelial ovarian cancer cell lines.MicroRNA-7 inhibits tumor metastasis and reverses epithelial-mesenchymal transition through AKT/ERK1/2 inactivation by targeting EGFR in epithelial ovarian cancerFunctional characterisation of a novel ovarian cancer cell line, NUOC-1.Overexpression of FOXM1 predicts poor prognosis and promotes cancer cell proliferation, migration and invasion in epithelial ovarian cancer.A potential anti-tumor herbal medicine, Corilagin, inhibits ovarian cancer cell growth through blocking the TGF-β signaling pathways.Functional expression of TWEAK and the receptor Fn14 in human malignant ovarian tumors: possible implication for ovarian tumor intervention.Gene expression profile analysis identifies metastasis and chemoresistance-associated genes in epithelial ovarian carcinoma cells.Chloride channel-3 promotes tumor metastasis by regulating membrane ruffling and is associated with poor survival.ADP-ribosylation factor-like 4C (ARL4C), a novel ovarian cancer metastasis suppressor, identified by integrated genomics.PDCD6 is an independent predictor of progression free survival in epithelial ovarian cancerTransformation of epithelial ovarian cancer stemlike cells into mesenchymal lineage via EMT results in cellular heterogeneity and supports tumor engraftmentExosomes mediated pentose phosphate pathway in ovarian cancer metastasis: a proteomics analysis.53BP1 suppresses tumor growth and promotes susceptibility to apoptosis of ovarian cancer cells through modulation of the Akt pathwayBasigin-2 is the predominant basigin isoform that promotes tumor cell migration and invasion and correlates with poor prognosis in epithelial ovarian cancerAn Advanced Orthotopic Ovarian Cancer Model in Mice for Therapeutic Trials.Silencing of IQGAP1 by shRNA inhibits the invasion of ovarian carcinoma HO-8910PM cells in vitro.Endogenous human CaMKII inhibitory protein suppresses tumor growth by inducing cell cycle arrest and apoptosis through down-regulation of the phosphatidylinositide 3-kinase/Akt/HDM2 pathway.MiR-124 inhibits the migration and invasion of ovarian cancer cells by targeting SphK1.Complement component 7 (C7), a potential tumor suppressor, is correlated with tumor progression and prognosis.
P2860
Q31083068-DEF26F1D-B3EE-4BE9-A524-B43234E5058BQ33338286-DEA240C6-8C9C-4AB2-BD92-7D5A9AD6941FQ33590704-17756CAD-2290-40E5-98AB-D2209D30124BQ33688843-0D6D4D3A-12D4-4A6B-8505-201B715F84A5Q33778640-C5B05BAC-232A-476D-9D33-7C715DB3A96AQ34587399-2CBBA80F-337E-4772-9A9F-64DD3CE241F0Q34613065-1382D0F1-2081-4DEB-B312-4E65BF476255Q34675214-A9A6259F-46B2-423C-8C44-99EF51F91390Q35273723-62A68ED6-FD2B-4C35-A566-511A3F2B4116Q35440069-E509B290-6942-4F7D-8F3B-1183AAE8F150Q35834117-35FA7F64-5BA8-4D2A-8F19-53FA004058E8Q36434358-41FC2F21-6F40-4CDD-8436-6A4503D74933Q36511698-204798F4-D8AD-43B7-9064-535AADC4E689Q36642343-B9300F1F-A172-4F8A-B4E5-DEF5C62AD508Q36767255-C921869A-185B-430E-8664-84BF8800781CQ36768578-FFC1D0C6-5887-4934-A046-E30BE481F5DFQ37061577-7166D70F-7443-411D-839B-089FA0DC88BCQ37375646-2D1343A2-2407-4695-BBA9-0E2F61FE03C5Q37427776-E52609ED-68FF-457D-B603-4BE84A63751EQ37699277-2A372DA0-BB04-4A5A-A2FC-E8E6884D7749
P2860
Establishment of a highly metastatic human ovarian cancer cell line (HO-8910PM) and its characterization.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Establishment of a highly meta ...... 0PM) and its characterization.
@ast
Establishment of a highly meta ...... 0PM) and its characterization.
@en
type
label
Establishment of a highly meta ...... 0PM) and its characterization.
@ast
Establishment of a highly meta ...... 0PM) and its characterization.
@en
prefLabel
Establishment of a highly meta ...... 0PM) and its characterization.
@ast
Establishment of a highly meta ...... 0PM) and its characterization.
@en
P2093
P1476
Establishment of a highly meta ...... 10PM) and its characterization
@en
P2093
Yongliang G
P304
P4510
P577
1999-06-01T00:00:00Z